About this trial
The goal of this qualitative study is to explore the impact of antiviral treatment, or none, for chronic hepatitis B virus on the non-clinical (social) harms experienced by migrant populations living in the UK.
Two groups of participants living with hepatitis B virus will be interviewed, those taking the daily treatment, and those not prescribed any treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Chronic HBsAg
Able to give informed consent in English
Able to converse in English
Any migrant population member (non-UK) including if born overseas or in the UK
Disqualifiers
Emotionally distressed due to HBV diagnosis
Current episode of decompensated cirrhosis
Current diagnosis of hepatocellular carcinoma
Trial population
Adults living with chronic hepatitis B virus infection
Trial design
Other
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The qualitative Interview Topic Guide Questionnaire will thematically measure patients' experience of treatment, or not having treatment, for chronic hepatitis B virus infection.
A qualitative interview topic guide questionnaire on patient's experience of treatment, or no treatment, for hepatitis B virus infection. The coding scheme will be inductively derived by the study team and overarching themes that characterise patients' experiences will be determined.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: